People with fibromyalgia have different gut bacteria
A study that compared women with and without fibromyalgia has, for the first time, linked gut bacteria to the long-lasting disease and its main symptoms. Researchers in Canada identified 19
A study that compared women with and without fibromyalgia has, for the first time, linked gut bacteria to the long-lasting disease and its main symptoms. Researchers in Canada identified 19
Fibromyalgia affects 2-4 percent of the population and has no known cure. Symptoms include fatigue, impaired sleep, and cognitive difficulties, but the disease is most clearly characterized by widespread chronic
The microbiome plays a vital role in health. A recent study has investigated how viruses that kill gut bacteria influence these microbes. The findings make an already complicated picture much
Sure, potato chips, cookies, and hot dogs are chock-full of salt, sugar, fat, and calories. They can cause us to gain weight and put us at a higher risk of
4D pharma plc today announced that data from the completed Phase Ib clinical study of Thetanix® for the treatment of Crohn’s disease will be presented by the Lead Investigator, Richard Hansen,
Have you ever wonder why a drug that works for someone else doesn’t seem to work for you? It is still a quite mystery for scientists also why certain drugs
4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announced the presentation of a poster detailing its Phase I/II clinical study of MRx0518 combined
We share our bodies with trillions of microbes that are critical to staying healthy, but now scientists are getting a much-needed close look at how those bugs can get out
A number of physiological and psychological changes occur as we age, and many studies have shown that our gut microbiome also changes as we grow older. A fascinating new study
According to the latest market report published by Persistence Market Research, titled ‘Microbiome Therapeutics Market Potential: Global Pipeline Analysis and Assessment 2018 – 2025’, the global microbiome therapeutics marketis expected